A couple seeks counseling about the risk of their child developing a recessive disorder. The woman is affected and upon further testing it is determined that the man is a carrier. Which of the following is true?

Choice A reason: Renal stones, also known as kidney stones, are a common complication of gouty arthritis. Gout is caused by the accumulation of uric acid crystals in the joints, leading to inflammation and pain. High levels of uric acid in the blood can also lead to the formation of uric acid stones in the kidneys. These stones can cause severe pain, urinary obstruction, and increase the risk of urinary tract infections. Therefore, patients with gout are at a higher risk of developing renal stones due to the elevated uric acid levels.

Choice B reason: Cholelithiasis, or gallstones, is not directly associated with gouty arthritis. Gallstones are formed from cholesterol or bilirubin in the gallbladder and are more commonly related to conditions such as obesity, diabetes, and certain liver diseases. While they can cause significant health issues, they are not a typical complication of gout.

Choice C reason: Liver failure is not a common complication of gouty arthritis. While liver disease can occur due to other underlying conditions or as a side effect of medications used to treat gout, it is not directly caused by the elevated uric acid levels or the inflammation characteristic of gout.

Choice D reason: Myocarditis, which is inflammation of the heart muscle, is not typically associated with gouty arthritis. Myocarditis can be caused by infections, autoimmune diseases, or other factors, but it is not a known complication of elevated uric acid levels or gout.

Choice A reason: Nucleoside reverse transcriptase inhibitors (NRTIs) are one of the main classes of antiretroviral drugs used in the treatment of HIV. They work by inhibiting the reverse transcriptase enzyme, which is crucial for the replication of the virus. By blocking this enzyme, NRTIs help prevent the virus from multiplying and reduce the viral load in the body.

Choice B reason: RNA transfer inhibitors are not a recognized class of drugs used in the management of HIV. The main classes of antiretroviral drugs include NRTIs, non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors, fusion inhibitors, integrase inhibitors, and entry inhibitors, but RNA transfer inhibitors are not among them.

Choice C reason: Fusion inhibitors are a class of antiretroviral drugs that prevent HIV from entering the host cells. They work by blocking the fusion process between the viral envelope and the host cell membrane, thereby preventing the virus from injecting its genetic material into the host cell. Fusion inhibitors are used as part of combination therapy to manage HIV infection.

Choice D reason: Protease inhibitors are another essential class of antiretroviral drugs used to treat HIV. They work by inhibiting the protease enzyme, which is necessary for the virus to produce mature viral particles. By blocking this enzyme, protease inhibitors prevent the production of functional viral particles, thus reducing the viral load in the body.

Choice E reason: DNA polymerase inhibitors are not used in the management of HIV. They are typically used to treat other viral infections, such as herpesviruses. The management of HIV primarily involves drugs that target the enzymes specific to HIV replication, such as reverse transcriptase, protease, and integrase